ADMA Biologics, Inc. (ADMA)
16.29
+0.19
(+1.18%)
USD |
NASDAQ |
Feb 23, 16:00
16.28
-0.01
(-0.06%)
After-Hours: 19:59
ADMA Biologics Market Cap : 3.877B for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Marker Therapeutics, Inc. | 24.51M |
| Arcutis Biotherapeutics, Inc. | 3.223B |
| CorMedix, Inc. | 552.31M |
| AtriCure, Inc. | 1.583B |
| Ligand Pharmaceuticals, Inc. | 3.609B |
Market Cap Related Metrics
| PE Ratio | 19.13 |
| PS Ratio | 8.201 |
| PEG Ratio | 0.0919 |
| Price to Book Value | 8.991 |
| Price to Free Cash Flow | 98.67 |
| Price | 16.29 |
| Earnings Yield | 5.23% |
| PEGY Ratio | 0.0919 |
| Operating PE Ratio | 23.99 |
| Normalized PE Ratio | 18.84 |